Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

36.58
Delayed Data
As of 4:02pm ET
 -0.16 / -0.44%
Today’s Change
25.98
Today|||52-Week Range
38.06
+13.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.9B

Company Description

Haemonetics Corp. is a global healthcare company, which provides innovative blood management solutions. Its products are divided into four categories: Plasma, Blood Center, Hospital and Software Solutions. The Plasma product line includes plasma collection for fractionation. The Blood Center product line offers automated blood component and manual blood collection systems to blood collection centers. The Hospital product line provides a range of blood management solutions that significantly improve a hospital's system for acquiring blood. The Software Solutions product line offers solutions for blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution and transfusion management. Haemonetics was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Contact Information

Haemonetics Corp.
400 Wood Road
Braintree Massachusetts 02184-9114
P:(781) 848-7100
Investor Relations:
(781) 356-9402

Employees

Shareholders

Mutual fund holders61.33%
Other institutional40.09%
Individual stakeholders1.88%

Top Executives

Christopher SimonPresident, Chief Executive Officer & Director
William P. BurkeChief Financial Officer
Sandra L. JesseSecretary, Chief Legal Officer & Executive VP
Byron SelmanPresident-Global Markets
Dan GoldsteinChief Accounting Officer